Pharma firm voluntarily licences cancer drug in novel deal

01-11-2022

Pharma firm voluntarily licences cancer drug in novel deal

shutterstock_646752871_Mironmax Studio

Agreement is 'first ever' public health focused voluntary licensing deal on a cancer medicine| Opportunities for selected generic manufacturers


Novartis, MPP, cancer, voluntary licensing, generics

LSIPR